Skip to main content
Log in

Effect of somatostatin and thyrotropin-releasing hormone on cholecystokinin-induced gallbladder emptying

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The effect of somatostatin (0.05 and 1.5 μg/kg/hr) and of thyrotropin-releasing hormone (0.1 and 1.0 μg/kg/hr) on cholecystokinin-induced gallbladder emptying was studied in healthy volunteers by means of real-time ultrasonography. In addition, the action of increasing doses (0.05, 0.15, 0.45, and 1.35 μg/kg/hr) of somatostatin on resting gallbladder volume was also evaluated. Somatostatin, at the dose of 0.05 μg/kg/hr (shown to produce blood levels similar to those measured after a meal) significantly inhibited the gallbladder contraction in response to cholecystokinin. Kinetic analysis showed that the interaction of somatostatin and cholecystokinin is of the noncompetitive type. The higher dose of the peptide (1.5 μg/kg/hr) completely suppressed cholecystokinin-induced gallbladder contraction. In experiments carried out using somatostatin alone, a progressive increase in gallbladder volume in response to increasing doses of peptide was observed. The administration of either dose of thyrotropin-releasing hormone did not affect gallbladder emptying in any of the subjects studied. It is concluded that somatostatin is a potent inhibitor of cholecystokinin action on the gallbladder. The clear effectiveness of a very low, presumably physiological, dose indicates that somatostatin may play a physiological role in the regulation of gallbladder motor activity and provides further evidence that the peptide may act as a true hormone in man. Thyrotropin-releasing hormone does not seem to affect gallbladder motility, at least under the experimental conditions of the present study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Creutzfeldt W, Lankisch PG, Fölsch UR: Hemmung der sekretin und cholezystokinin-pankreozymin-induzierten saft und enzymsekretion des pankreas und der gallenblasenkontraktion beim menschen durch somatostatin. Dtsch Med Wochenschr 100:1135–1138, 1975

    Google Scholar 

  2. René E, Danzinger RG, Hofmann AF, Nakagaki M: Pharmacological effect of somatostatin on bile formation in the dog. Enhanced ductular reabsorption as the major mechanism of anticholeresis. Gastroenterology 84:120–129, 1983

    Google Scholar 

  3. Schusdziarra V, Harris V, Conlon JM, Arimura A, Unger RH: Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog. J Clin Invest 62:509–518, 1978

    Google Scholar 

  4. Zyznar ES, Pietri AO, Harris V, Unger RH: Evidence for the hormonal status of somatostatin in man. Diabetes 30:883–886, 1981

    Google Scholar 

  5. Penman E, Wass JAH, Medbak S, Morgan L, Lewis JM, Besser GM, Rees LH: Response of circulating immunoreactive somatostatin to nutritional stimuli in normal subjects. Gastroenterology 81:692–699, 1981

    Google Scholar 

  6. Schusdziarra V, Harris V, Arimura A, Unger RH: Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients. Endocrinology 104:1705–1708, 1979

    Google Scholar 

  7. Johansson C, Wisen O, Efendic S, Uvnäs-Wallensten K: Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. Digestion 22:126–137, 1981

    Google Scholar 

  8. Souquet JC, Rambliere R, Riou JP, Beylot M, Cohen R, Mornex R, Chayvialle JA: Hormonal and metabolic effects of near physiological increase of plasma immunoreactive somatostatin 14. J Clin Endocrinol Metab 56:1076–1079, 1983

    Google Scholar 

  9. O'Shaughnessy DJ, Long RG, Adrian TE, Christofides ND, Ghatei MA, Sarson DL, Bloom SR: Somatostatin-14 modulates postprandial glucose levels and release of gastrointestinal and pancreatic hormones. Digestion 31:234–242, 1985

    Google Scholar 

  10. Schusdziarra V, Zyznar E, Rouiller D, Boden G, Brown JC, Arimura A, Unger RH: Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis. Science 207:530–532, 1980

    Google Scholar 

  11. Morley JE, Garvin TJ, Pekary AE, Hershman JM: Thyrotropin-releasing hormone in the gastrointestinal tract. Biochem Biophys Res Commun 79:314–318, 1977

    Google Scholar 

  12. Dolva LA, Hanssen KF, Aadland E, Sand T: Thyrotropin-releasing hormone immunoreactivity in the gastrointestinal tract of man. J Clin Endocrinol Metab 56:524–529 1983

    Google Scholar 

  13. Dolva LO, Hanssen KF, Berstad A, Frey HMM: Thyrotropin-releasing hormone inhibits the pentagastrin-stimulated gastric secretion in man. A dose response study. Clin Endocrinol 10:281–286, 1979

    Google Scholar 

  14. Gullo L, Labò G: Thyrotropin-releasing hormone inhibits pancreatic enzyme secretion in humans. Gastroenterology 80:735–739, 1981

    Google Scholar 

  15. Dolva LO, Stadaas JO: Actions of thyrotropin-releasing hormone on gastrointestinal functions in man. III. Inhibition of gastric motility in response to distension. Scand J Gastroenterol 14:419–423, 1979

    Google Scholar 

  16. Gullo L, Bolondi L, Priori P, Casanova P, Labò G: Inhibitory effect of atropine on cholecystokinin-induced gallbladder contraction in man. Digestion 29:209–213, 1984

    Google Scholar 

  17. Dowd JE, Riggs DS: A comparison of estimates of Michaelis-Menten kinetic constants from various linear transformations. J Biol Chem 240:863–869, 1965

    Google Scholar 

  18. Goldstein A: Biostatistics. An Introductory Text. New York, Macmillan Company, 1964

    Google Scholar 

  19. Tallarida RJ, Murray RB: Manual of Pharmacological Calculations with Computer Programs. New York, Springer-Verlag, 1981

    Google Scholar 

  20. Johansson C, Kollberg B, Efendic S, Uvnäs-Wallensten K: Effects of graded doses of somatostatin on gallbladder emptying and pancreatic enzyme output after oral glucose in man. Digestion 22:24–31, 1981

    Google Scholar 

  21. MacGregor IL, Deveney C, Way LW, Meyer JH: The effect of acute hyperglycemia on meal stimulated gastric, biliary, and pancreatic secretion and serum gastrin. Gastroenterology 70:197–202, 1976

    Google Scholar 

  22. Guillemin R: Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus. Endocrinology 99:1653–1654, 1976

    Google Scholar 

  23. Schusdziarra V: Somatostatin — physiological and pathophysiological aspects. Scand J Gastroenterol 18 (Suppl 82): 69–84, 1983

    Google Scholar 

  24. Krejs GJ, Orci L, Conlon JM, Ravazzola M, Davis GR, Raskin P, Collins SM, McCarthy DM, Baetens D, Rubenstein A, Aldor TAM, Unger RH: Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med 301:285–292, 1979

    Google Scholar 

  25. Shafer RB, Marlette JM, Morley JE: The effects of lipomul, CCK, and TRH on gallbladder emptying. Clin Nucl Med 8:66–69, 1983

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gullo, L., Bolondi, L., Scarpignato, C. et al. Effect of somatostatin and thyrotropin-releasing hormone on cholecystokinin-induced gallbladder emptying. Digest Dis Sci 31, 1345–1350 (1986). https://doi.org/10.1007/BF01299813

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01299813

Keywords

Navigation